Who owns Oruka Therapeutics (ORKA)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Oruka Therapeutics (ORKA) in their latest 13F filing, with $294.1M between them. Peter Kolchinsky gives it the most weight: 1.29% of the reported portfolio. In their latest reported quarter, Peter Kolchinsky and Polen Capital team opened a position; Andreas Halvorsen reduced.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Peter Kolchinsky, $148M
- Largest weight
- Peter Kolchinsky, 1.29%of their portfolio
- Combined value
- $294.1M
- Bought last quarter
- 2
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Peter KolchinskyRA Capital Management | 1.29% | $148M | 1.55M | New | +1.55M | Q2 2026 |
| 2 | Andreas HalvorsenViking Global Investors | 0.41% | $143.1M | 1.5M | ▼ Reduced 44% | −1.16M | Q2 2026 |
| 3 | Polen Capital teamPolen Capital Management | 0.03% | $3M | 36.27K | New | +36.27K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 36.27K | $3M | 1 | 0 |
| Q2 2026 | 157 | 2 | 3.06M | $291M | 1 | 1 |
| Q1 2026 | 157 | 1 | 2.67M | $130.8M | 0 | 0 |
| Q4 2025 | 157 | 1 | 2.67M | $80.8M | 0 | 0 |
| Q3 2025 | 157 | 1 | 2.67M | $51.3M | 1 | 0 |
| Q2 2025 | 157 | 0 | — | — | 0 | 0 |
| Q1 2025 | 156 | 0 | — | — | 0 | 0 |
| Q4 2024 | 156 | 0 | — | — | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Polen Capital team | 36.27K | — | — | — | — | — | — | — |
| Peter Kolchinsky | · | 1.55M | — | — | — | — | — | — |
| Andreas Halvorsen | · | 1.5M | 2.67M | 2.67M | 2.67M | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own ORKA?
In their latest 13F filings: Peter Kolchinsky (1.29% of the portfolio, $148M), Andreas Halvorsen (0.41% of the portfolio, $143.1M), Polen Capital team (0.03% of the portfolio, $3M).
Who bought ORKA last quarter?
Peter Kolchinsky (new position), Polen Capital team (new position). “Last quarter” is each investor's latest reported quarter.
Who sold ORKA last quarter?
Reduced: Andreas Halvorsen (44% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Oruka Therapeutics (ORKA)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ORKA/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ORKA by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.